Search

The European Artificial Intelligence Act (AI Act) has profound implications for technological innovation in the medical and health care sector, transcending the boundaries of existing legal frameworks such as the Medical Device Regulation (MDR) and the General Data Protection Regulation (GDPR). This paper examines basic regulatory choices of the AI Act relevant for the field of digital health innovations by contextualizing its main goals, key obligations, and addressed actors. In light of these considerations, we present a scoping literature review that identifies potential regulatory challenges for stakeholders engaged in research, innovation and healthcare. Building on this, we point to concepts and methodologies to overcome such challenges in a way fostering innovation while realizing key constitutional and societal interests at the same time. [ABSTRACT FROM AUTHOR]

With an eye on the Indian economic scene, this research article investigates the legal obstacles of implementing block chain technology in companies. The paper uses quantitative analysis to evaluate how block chain innovation and startup expansion are affected by legal environments. Through an analysis of the Indian startup scene, the study seeks to shed light on the legal obstacles preventing block chain acceptance and present suggestions for a friendly legislative climate. Complementing the Sustainable Development Goals (SDGs) of the United Nations, the study also emphasises block chain's potential in advancing openness, security, and efficiency. This thorough study aims to guide stakeholders, businesses, and legislators on using block chain for inclusive and environmentally friendly development. By understanding the legal barriers in the Indian startup ecosystem, stakeholders can work towards creating a conducive environment for block chain technology to thrive. With its ability to enhance transparency and streamline processes, block chain has the potential to drive progress towards achieving the SDGs. By leveraging the insights from this study, businesses and policymakers can harness the power of block chain to promote sustainable and inclusive development. This collaboration can lead to innovative solutions that address social and environmental challenges while promoting economic growth. Through strategic partnerships and policy reforms, block chain technology can be harnessed to create a more sustainable future for all. [ABSTRACT FROM AUTHOR]

The development of new antibiotics is paramount in combating the escalating threat of antibiotic resistance, which poses significant challenges to global public health. However, this endeavor is hampered by regulatory and economic obstacles that impede the translation of scientific innovations into clinically effective therapies. Regulatory requirements, market dynamics, and reimbursement policies create barriers to antibiotic research and development, leading to a limited pipeline of novel antimicrobial agents. Addressing these challenges requires collaborative efforts from policymakers, regulators, pharmaceutical companies, and the healthcare community. Regulatory reforms, market-based incentives, and sustainable antibiotic use strategies are essential for expediting antibiotic development, stimulating investment, and preserving the effectiveness of existing antibiotics. This review examines the regulatory and economic challenges in antibiotic development and proposes strategies to overcome them, emphasizing the importance of innovation, stewardship, and global cooperation in safeguarding the efficacy of antibiotic therapies. [ABSTRACT FROM AUTHOR]